133 related articles for article (PubMed ID: 15363277)
1. [Clinical significance of expression of VEGF and bFGF in thyroid carcinoma].
Tian XF; Zhang XW; Chen RX; Wang JW; Zhang D
Zhonghua Wai Ke Za Zhi; 2004 Jul; 42(14):864-6. PubMed ID: 15363277
[TBL] [Abstract][Full Text] [Related]
2. [Expression and significance of VEGF, VEGF-C, and VEGF-D in papillary thyroid carcinoma].
Jiang HG; Gao M; Tang WP; Li FH; Cai QZ
Ai Zheng; 2005 Sep; 24(9):1136-9. PubMed ID: 16159441
[TBL] [Abstract][Full Text] [Related]
3. Increased expression of vascular endothelial growth factor C in papillary thyroid carcinoma correlates with cervical lymph node metastases.
Yu XM; Lo CY; Chan WF; Lam KY; Leung P; Luk JM
Clin Cancer Res; 2005 Nov; 11(22):8063-9. PubMed ID: 16299237
[TBL] [Abstract][Full Text] [Related]
4. [Expression of mucin-l and beta-catenin in papillary thyroid carcinoma and the clinical significance thereof].
He F; Li H; Li WS; Dong XH
Zhonghua Yi Xue Za Zhi; 2009 Feb; 89(6):393-6. PubMed ID: 19567117
[TBL] [Abstract][Full Text] [Related]
5. [Expression of VEGF, bFGF and ER in endometrial carcinoma].
Bai X; Mi R
Zhonghua Zhong Liu Za Zhi; 2001 May; 23(3):211-3. PubMed ID: 11783088
[TBL] [Abstract][Full Text] [Related]
6. [Vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF) expression in superficial transitional cell bladder carcinoma].
Guo ZH; Mei H; Huang J; Li SY
Ai Zheng; 2003 Mar; 22(3):307-9. PubMed ID: 12654193
[TBL] [Abstract][Full Text] [Related]
7. Clinical relevance of vascular endothelial growth factor for thyroid neoplasms.
Huang SM; Lee JC; Wu TJ; Chow NH
World J Surg; 2001 Mar; 25(3):302-6. PubMed ID: 11343180
[TBL] [Abstract][Full Text] [Related]
8. Papillary carcinoma of the thyroid: low expression of NCAM (CD56) is associated with downregulation of VEGF-D production by tumour cells.
Scarpino S; Di Napoli A; Melotti F; Talerico C; Cancrini A; Ruco L
J Pathol; 2007 Aug; 212(4):411-9. PubMed ID: 17573672
[TBL] [Abstract][Full Text] [Related]
9. [Expression of VEGF-C and angiogenesis, and lymphangiogenesis in papillary thyroid carcinoma].
Liang QC; Wei QY; Fan SQ
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2006 Jun; 31(3):414-6, 419. PubMed ID: 16859137
[TBL] [Abstract][Full Text] [Related]
10. [Clinical significance of HIF-1 alpha,VEGF and VEGF-C expression in papillary thyroid carcinoma].
Wang Y; Hua Q
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2007 Mar; 21(5):204-6, 208. PubMed ID: 17536453
[TBL] [Abstract][Full Text] [Related]
11. [Clinical significance of detection on lymphatic microvessel, lymphatic microvessel density and vascular endothelial growth factor-C in patients with colorectal carcinoma].
Fan YZ; Li GM; Huang GP; Li XP
Zhonghua Wei Chang Wai Ke Za Zhi; 2006 Nov; 9(6):477-82. PubMed ID: 17143789
[TBL] [Abstract][Full Text] [Related]
12. [Expression and clinical significance of vascular endothelial growth factor C and D in nasopharyngeal carcinoma].
Zhao GG; Xiang XJ; He YJ
Ai Zheng; 2007 Jan; 26(1):90-5. PubMed ID: 17222375
[TBL] [Abstract][Full Text] [Related]
13. Increased expression of valosin-containing protein (p97) is correlated with disease recurrence in follicular thyroid cancer.
Yamamoto S; Tomita Y; Uruno T; Hoshida Y; Qiu Y; Iizuka N; Nakamichi I; Miyauchi A; Aozasa K
Ann Surg Oncol; 2005 Nov; 12(11):925-34. PubMed ID: 16189643
[TBL] [Abstract][Full Text] [Related]
14. [Expression of angiogenic factors and their clinical significances in acute myeloid leukemia].
Wang Y; Xiao ZJ; Liu P; Peng Z; Han ZC
Ai Zheng; 2004 Nov; 23(11 Suppl):1423-7. PubMed ID: 15566649
[TBL] [Abstract][Full Text] [Related]
15. Angiogenesis and lymphangiogenesis in thyroid proliferative lesions: relationship to type and tumour behaviour.
de la Torre NG; Buley I; Wass JA; Turner HE
Endocr Relat Cancer; 2006 Sep; 13(3):931-44. PubMed ID: 16954441
[TBL] [Abstract][Full Text] [Related]
16. [mRNA expression of basic fibroblast growth factor and hepatocyte growth factor in gastric carcinoma and significance thereof].
Ru GQ; Zhao ZS; Tang QL; Xu WJ
Zhonghua Yi Xue Za Zhi; 2008 Jul; 88(29):2030-5. PubMed ID: 19080429
[TBL] [Abstract][Full Text] [Related]
17. Correlation of E-cadherin, VEGF, COX-2 expression to prognostic parameters in papillary thyroid carcinoma.
Erdem H; Gündogdu C; Sipal S
Exp Mol Pathol; 2011 Jun; 90(3):312-7. PubMed ID: 21335003
[TBL] [Abstract][Full Text] [Related]
18. [Expression and significance of VEGF-C and VEGF-D in differentiated thyroid carcinoma].
Luo H; Li J; Yang T; Wang J
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2009 Jun; 23(12):531-4. PubMed ID: 19771906
[TBL] [Abstract][Full Text] [Related]
19. [Difference in expression of VEGF, bFGF and their receptors between the young and postmenopausal women with breast cancer].
Yi WJ; Tang ZH; Yang ZL; Yu MY; Li YS; Chen GN
Zhonghua Zhong Liu Za Zhi; 2003 Mar; 25(2):141-4. PubMed ID: 12795839
[TBL] [Abstract][Full Text] [Related]
20. VEGF-C and COX-2 expression in papillary thyroid cancer.
Siironen P; Ristimäki A; Narko K; Nordling S; Louhimo J; Andersson S; Haapiainen R; Haglund C
Endocr Relat Cancer; 2006 Jun; 13(2):465-73. PubMed ID: 16728574
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
